Amphastar Pharmaceuticals (AMPH) Operating Expenses (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Operating Expenses of $56.7 million for Q1 2026, up 18.21% year-over-year from $48.0 million in Q1 2025, and down 3.57% quarter-over-quarter from $58.8 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Operating Expenses (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Operating Expenses history runs 14 years deep, the most recent figure standing at $56.7 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 18.21% year-over-year to $56.7 million; the TTM figure through Mar 2026 stood at $238.5 million (up 27.96% YoY), while the FY2025 annual figure was $215.7 million, up 28.03% from the prior year.
- Operating Expenses for Q1 2026 stood at $56.7 million, down from $58.8 million in the prior quarter.
- The five-year high for Operating Expenses was $78.7 million in Q3 2025, with the low at $33.3 million in Q4 2022.
- The 5-year median for Operating Expenses is $42.1 million (2024), against an average of $44.8 million.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses dropped 6.98% in 2023, then surged 66.79% in 2025.
- Amphastar Pharmaceuticals' Operating Expenses stood at $33.3 million in 2022, then climbed by 26.47% to $42.2 million in 2023, then rose by 18.86% to $50.1 million in 2024, then rose by 17.31% to $58.8 million in 2025, then decreased by 3.57% to $56.7 million in 2026.
- Business Quant data shows AMPH's Operating Expenses at $56.7 million in Q1 2026, $58.8 million in Q4 2025, and $78.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn | 53.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.74 Mn |
| Mar 31, 2026 | 56.69 Mn |
| Dec 31, 2025 | 58.79 Mn |
| Sep 30, 2025 | 78.70 Mn |
| Jun 30, 2025 | 44.31 Mn |
| Mar 31, 2025 | 47.96 Mn |
| Dec 31, 2024 | 50.11 Mn |
| Sep 30, 2024 | 47.18 Mn |
| Jun 30, 2024 | 41.12 Mn |
| Mar 31, 2024 | 42.09 Mn |
| Dec 31, 2023 | 42.16 Mn |
| Sep 30, 2023 | 35.73 Mn |
| Jun 30, 2023 | 35.84 Mn |
| Mar 31, 2023 | 40.41 Mn |
| Dec 31, 2022 | 33.34 Mn |
| Sep 30, 2022 | 35.28 Mn |
| Jun 30, 2022 | 38.53 Mn |
| Mar 31, 2022 | 34.21 Mn |
| Dec 31, 2021 | 31.98 Mn |
| Sep 30, 2021 | 26.41 Mn |